Esperion Therapeutics, Inc. · NASDAQ:ESPR

Goldman Sachs Group Inc reported a 6.70% stake in Esperion Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 13, 2026

Goldman Sachs Group Inc reported a 6.70% stake in Esperion Therapeutics, Inc., 17,222,156 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).

Stake
6.70%
Shares
17,222,156
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.6.70%17,222,156
GOLDMAN SACHS & CO. LLC6.70%17,222,156

Source

View original at SEC

Related